Search by Drug Name or NDC
NDC 00641-6234-10 Succinylcholine Chloride 20 mg/mL Details
Succinylcholine Chloride 20 mg/mL
Succinylcholine Chloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is SUCCINYLCHOLINE CHLORIDE DIHYDRATE.
Product Information
| NDC | 00641-6234 |
|---|---|
| Product ID | 0641-6234_5270b37b-026b-499f-b33c-140f5262bc8d |
| Associated GPIs | |
| GCN Sequence Number | 076717 |
| GCN Sequence Number Description | succinylcholine/sod Cl,iso/PF SYRINGE 100 MG/5ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 42466 |
| HICL Sequence Number | 043335 |
| HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE IN SODIUM CHLORIDE,ISO-OSMOTIC/PF |
| Brand/Generic | Generic |
| Proprietary Name | Succinylcholine Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Succinylcholine Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | SUCCINYLCHOLINE CHLORIDE DIHYDRATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA215143 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00641-6234-10 (00641623410)
| NDC Package Code | 0641-6234-10 |
|---|---|
| Billing NDC | 00641623410 |
| Package | 10 SYRINGE, PLASTIC in 1 CARTON (0641-6234-10) / 5 mL in 1 SYRINGE, PLASTIC |
| Marketing Start Date | 2022-03-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |